Oramed Pharmaceuticals Inc. (ORMP) Debt to Equity Ratio
Oramed Pharmaceuticals Inc. (ORMP) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2016-08-31 | 0.64 |
| 2017-08-31 | 1.01 |
| 2018-08-31 | 0.52 |
| 2019-08-31 | 0.79 |
| 2020-08-31 | 0.36 |
| 2021-08-31 | 0.10 |
| 2022-12-31 | 0.07 |
| 2023-12-31 | 0.35 |
| 2024-12-31 | 0.07 |
| 2025-12-31 | 0.16 |
Get Oramed Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("ORMP", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ORMP | $3.88 | +2.37% | 0.15M |
| 3 | ||||
| 4 | ||||
| 5 |